Important research being carried out in the University of Luxembourg’s Luxembourg Centre for Systems Biomedicine (LCSB) on Parkinson’s disease is having a global impact. Additionally, it plays a coordinating role in Luxembourg’s National Centre of Excellence in Research on Parkinson’s Disease (NCER-PD). This is a joint Parkinson’s disease research programme that includes several biomedical research partners committed to finding new ways to affect earlier diagnoses and develop better treatments.
To develop the sensor and the other clinical and pharmaceutical research for the NCER-PD project, LCSB researchers need to process huge amounts of data, corroborate the data and collaborate among five major partners. This collaborative computational infrastructure is possible because of the RESTENA Foundation’s world-class national research and education network.
The RESTENA Foundation provides essential infrastructure necessary for the work of the University of Luxembourg and nearly all of the NCER-PD project partners who are working to develop the next generation of diagnostic and treatment models for patients with Parkinson’s disease. Read more about it on the latest In The Field blog post.